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The epidemiological transition, the shift from infectious to chronic non-communicable 
diseases (NCDs), is well advanced in most European countries. Viewed from one perspective, 
we can understand this by focusing on changes to people’s lifestyles and behaviours. 
However, a contrasting view draws attention to broader, social and environmental features 
that are unfavourable to health. The World Health Organization (WHO) slogan ‘Make the 
healthy choice the easier choice’ attempts to bridge these two views. It recognises the choices 
that individuals have in consuming healthier products, or taking exercise, but also seems to 
acknowledge that consumer ‘choices’ are heavily influenced by other factors beyond the 
individual’s power. Amongst these factors are the strategies that corporations pursue to make 
unhealthy choices more likely. Thus, public health is inevitably confronted with the question 
of how to interact with commercial interests when it comes to tackling the NCD epidemic. 
 
The engagement of public health practitioners and researchers with tobacco industry is now 
highly controversial leading many scholars to eschew interactions with the industry (1). 
Reflecting this, many leading journals now refuse to publish tobacco industry funded research 
(2). Yet many public health officials consider dealing with the processed food, soft drink and 
alcohol industries as normal practice, treating them as legitimate partners in improving 
population health (3). What is the rationale behind such different approaches to dealing with 
these industries, given that their products have a significant adverse impact on population 
health and their business strategies use similar approaches when it comes to marketing, 
product design, policy influence, and challenging evidence of harm (4, 5)?  
 
In part, the answer lies in the extensive research linking the consumption of tobacco products 
to a range of negative health outcomes and the activities of the tobacco industry (4). As a 
result of a series of internal leaks followed by litigation against major tobacco companies in 
the US, internal tobacco company documents have entered the public realm (6). These 
highlight that senior managers of tobacco companies have (amongst other things): lied about 
how addictive tobacco products are, worked to increase the addictiveness of products; 
targeted young children as new product ‘markets’; and worked to restrain policies that aim to 
limit tobacco consumption and the influence of tobacco companies (see e.g. (7)). These 
revelations led to the conceptualisation of the tobacco industry as a key NCD ‘vector’ (4). 
Public health efforts to denormalise tobacco have effectively undermined public and political 
legitimacy of tobacco industry actors in selected policy contexts, where industry 
representatives are increasingly excluded from tobacco control debates (8). However, the 
growing popularity of e-cigarettes is threatening the cohesion of the movement to control 
tobacco and offering new avenues through which tobacco industry actors can access policy 
makers (9). 
 
Processed food, alcohol and soft drink industries tend to argue (as the tobacco industry used 
to claim) that it is the individual’s personal responsibility to choose healthier options, for 
example by exercising, eating healthy diets and reducing the intake of less healthy products. 
The CEO of Pepsi Co, Indra Nooyi, has, for example, argued that PepsiCo is an ‘ethical’ 
company. She pointed out that her company offers a selection of products, ranging from 
healthy to less healthy. This view is frequently reinforced through advertising, news stories 
and television programmes and, in many cases, government policies. From this perspective, 
considering the corporate interests relating to the production and marketing of products as 
social determinants of NCDs makes sense. However, these actors often portray themselves as 
‘part of the solution’ (10) to the health crises that their products exacerbate. Thus, the 
development of reformulated products, changes to labelling, support for ‘educational’ 
initiatives, and the implementation of self-regulatory codes of practice are framed as 
appropriate strategies towards the control of NCDs. 
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The health harms associated with the tobacco, alcohol, and processed food industries are 
significant. Research shows that alcohol and obesity contribute significantly to unfavorable 
health outcomes (e.g. in pregnancy), often in a magnitude comparable to that of tobacco (4, 
11). Evidence also suggests that the health-related costs of products across these industries are 
similar and are perhaps highest for obesity (4, 12), rather than for tobacco. It is also clear that 
commercial interests and strategies across these sectors are similar, with industry 
representatives actively working to influence public and policy debates with a view to 
minimising the potential for regulation and maximising profit. Three examples suffice: 
 Recent research examining how alcohol industry actors in the UK have attempted to 
block policy proposals for minimum unit pricing identify strategies for policy 
influence that have been widely used by the tobacco industry, including: efforts to 
shape the available evidence-base (and the public’s, the media’s and policymakers’ 
understandings of the available evidence); direct and indirect lobbying; links to more 
credible organisations such as think tanks; and efforts to shape public perceptions of 
the industry (13), often via the media (14). 
 Corporate social responsibility (CSR) strategies are employed across all of these 
industries as means of shaping political contexts and informing public perceptions and 
consumption patterns. Despite these efforts to enhance their credibility, however, soda 
companies behave irresponsibly, for example by explicitly targeting children and 
setting goals to increase consumption (15).  
 In 2009-2012, a coalition of more than 50 food and beverage companies in the US 
invested US-$175 million to successfully lobby the Obama Administration not to 
pursue tougher (albeit still voluntary) nutritional standards for food items marketed to 
children (5). 
 
Why then, in light of such striking similarities, do people appear to view the tobacco industry 
so differently to processed food, soft drinks and alcohol industries? It may be, as Collin (1) 
argues, partly a consequence of the success of the tobacco control movement in promoting 
‘tobacco exceptionalism’ – the idea that the tobacco industry, as a result of both the health 
costs of tobacco products and our knowledge about prior industry behaviour, requires a 
uniquely strict approach to protecting public health policy from the interference of industry.  
 
Whilst it may be argued that tobacco is a uniquely harmful product – when used precisely as 
intended by manufacturers, tobacco will kill 50% of long term users – a growing body of 
research suggests that the industry which produces it is far from unique as a vector of disease. 
Given the magnitude of the public health challenge posed by NCDs, we need to move beyond 
identifying the current, contradictory approaches to these different industries. We propose 
four priorities for public health research. They should help us to better comprehend how these 
key industries are perceived, and how they influence the way politics and the public accepts 
them and their strategies. Researchers must: 
 
1. Develop tools to better understand how processed food, soft drinks, and alcohol 
industries influence public, media, political and policy debates. 
2. Examine how policymakers, journalists and the public view each of these industries 
and the products they market, and why. 
3. Consider how research in this area might support policies that are effective and 
evidence-informed, and will contribute towards promoting and protecting the public’s 
health. 
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4. Investigate the complex network of actors that constitute each of these distinct 
industries and identify any interactions between them. In this way, we can elucidate 
interests, strategies, and actions that are common across industries. 
 
In moving this agenda forward, public health researchers need to make space for developing 
“charismatic ideas” – convincing alternative scenarios of a healthier future (5). This is 
necessary to identify possibilities and new avenues to reduce harmful corporate influences on 
health. 
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